A Randomized Trial of Prophylactic Extended Carboplatin Infusion to Reduce Hypersensitivity Reactions in Recurrent Ovarian Cancer

Conclusions A prophylactic, extended carboplatin infusion was not associated with a decreased HSR rate. The overall low HSR rate suggests that premedication may help reduce HSRs.
Source: International Journal of Gynecological Cancer - Category: Cancer & Oncology Tags: Quality of Life Source Type: research